Antimicrobial therapy in the elderly

Medical Clinics of North America

Volumn 85, Issue 1, 2001, Pages 133-147

  Rajagopalan, Shobita ^b   Yoshikawa, Thomas T ^b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN; CLOXACILLIN; COTRIMOXAZOLE; DICLOXACILLIN; FLUCONAZOLE; ISONIAZID; ITRACONAZOLE; MACROLIDE; METICILLIN; MONOBACTAM; NAFCILLIN; OXACILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TIMENTIN; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; VANCOMYCIN;

AGED; AGING; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; CLINICAL FEATURE; DRUG CLEARANCE; DRUG COST; DRUG EFFECT; DRUG USE; GASTROINTESTINAL INFECTION; HUMAN; NEPHROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT INFECTION; REVIEW; SEIZURE; SIDE EFFECT; SKIN INFECTION; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

EID: 0035173009     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70308-4     Document Type: Article

References (67)

1. The macrolides: Erythromycin, clarithromycin and azithromycin
2. Urinary tract infections in geriatric inpatients: A comparative study of amoxicillin-clavulanic acid and cotrimoxazole
3. Effects of aging on the renal glomerulus
4. Quinolones: A practical review of clinical uses, dosing considerations, and drug interactions
5. Deep fungal infections
6. Methicillin-resistant Staphylococcus aureus infection
7. The monobactams
8. Fever response in elderly nursing home residents: Are the older truly colder?
9. Prevention and control of influenza: Recommendations of the Advisory Committee on immunization practices
10. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
11. Ciprofloxacin in treatment of chronic bacterial prostatitis
12. Clarithromycin pharmacokinetics in healthy young and elderly volunteers
13. An open study to compare the pharmacokinetics, safety and tolerability of multiple-dose regimen of azithromycin in young and elderly volunteers
14. Vancomycin
15. Aztreonam in the treatment of serious gram-negative infections in the elderly
16. Beta-lactam antibiotics
17. The pharmacokinetics of meropenem
18. Antibiotics choices in the elderly
19. Management of community-acquired pneumonia: Challenges, controversies and new therapeutic options
20. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia
21. Gangrene of the gall bladder: A complication of acute cholecystitis
22. In vitro and in vivo antibacterial activities of levofloxacin (1-ofloxacin) in optically active ofloxacin
23. Timentin in the treatment of symptomatic complicated urinary tract infections in adult patients
24. Monobactams
25. The role of cephalosporins in surgical prophylaxis
26. Cefepime: Overview of activity in vitro and in vivo
27. Quinolones
28. Quinolone antimicrobial agents
29. Meropenem versus cefuroxime plus gentamicin for treatment of serious infections in elderly patients
30. Aztreonam-flucloxacillin double beta-lactam treatment as empirical therapy of serious infections in very elderly patients
31. Clinical strategies for managing pneumonia in the elderly
32. Community acquired pneumonia requiring hospitalization: It is different in the elderly?
33. The cephalosporins
34. Antimicrobial therapy
35. Cephalosporins
36. Gram-negative bacillary bacteremia in the elderly: Incidence, ecology, etiology and mortality
37. Pharmacokinetics of co-trimoxazole and co-tetroxazine in geriatric patients
38. New macrolide antibiotics: Azithromycin and clarithromycin
39. Quinolone antimicrobial agents
40. Pharmacokinetics of antimicrobial agents with aging
41. Differentiating meropenem and imipenem/cilastatin
42. Clinical features of infections and significance of fever in the elderly nursing patient
43. Overview of bacterial infections of the skin and soft tissue and clinical experience with ticarcillin plus clavulanate potassium in the treatment
44. Quinolone resistance in clinical practice: Occurrence and importance
45. Antibiotic selection in the elderly patient
46. Tuberculosis
47. A randomized double-blind comparison of sulbactam/ampicillin and clindamycin for the treatment of aerobic and aerobic-anaerobic infections
48. Single dose pharmacokinetics of intravenous ampicillin plus sulbactam in healthy elderly and young adult subjects
49. Beta-lactamase inhibitors
50. Principles of prescribing medications
51. The cost of inappropriate use of anti-infective agents in older patients
52. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity
53. Trimethoprim-sulfamethoxazole: An assessment of more than 12 years of use
54. Why metronidazole is active against both bacteria and parasites
55. Viral infections in the elderly
56. Clinical pharmacology
57. Metronidazole
58. Pharmacokinetics of the trimethoprim-sulfamethoxazole combination in the elderly
59. Trimethoprim-sulfamethoxazole
60. Cephalosporin therapy in intra-abdominal infections: A multicenter randomized, comparative study of cefotetan, moxalactam, and cefoxitin
61. Urinary tract infection in older adults
62. Important infections in elderly persons
63. Antimicrobial therapy for the elderly patients
64. Empiric antimicrobial therapy
65. VRE, MRSA, PRP, and DRGNB in LTCF: Lessons to be learned from this alphabet